wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q30358635-87BCB470-3ABD-4080-8CE9-223A98EAB4D4
Q30358635-87BCB470-3ABD-4080-8CE9-223A98EAB4D4
BestRank
Statement
http://www.wikidata.org/entity/statement/Q30358635-87BCB470-3ABD-4080-8CE9-223A98EAB4D4
Randomized multicenter phase II trial comparing two schedules of etirinotecan pegol (NKTR-102) in women with recurrent platinum-resistant/refractory epithelial ovarian cancer.
P2860
Q30358635-87BCB470-3ABD-4080-8CE9-223A98EAB4D4
BestRank
Statement
http://www.wikidata.org/entity/statement/Q30358635-87BCB470-3ABD-4080-8CE9-223A98EAB4D4
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
bcc77b4e7cc66c7dfcccfe932fbb6b5bc0b8975a
P2860
A multicenter, phase I, dose-escalation study to assess the safety, tolerability, and pharmacokinetics of etirinotecan pegol in patients with refractory solid tumors